Home / World Marketplace / Archive by category Global Corporate Affairs (Page 10)

Archive by category Global Corporate Affairs

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12) After 12 weeks off therapy (week 25 of the study), 82% of evaluable patients (9 of 11) maintained a durable reduction in total polyp burden, [...]

Bitget October 2025 Protection Fund Maintains $741M Average Despite Slumptober

VICTORIA, Seychelles, Dec. 08, 2025 (Korea Bizwire) – Bitget, the world’s largest Universal Exchange (UEX), today released its October 2025 Protection Fund report, recording an average monthly valuation of $741,435,710 despite a challenging month across digital asset markets. The fund peaked at $811,031,000 on October 6 and registered a monthly low of $691,886,000 on October 17, [...]

Geneva College of Longevity Science and DrVibe.ai Launch the GCLS AI Academy for Longevity Sciences

First Multi-Agent AI System for Higher Longevity Education to Offer Free Courses and Pave the Way for a Master’s Degree in AI in Healthcare New Website: https://gcls.ai GENEVA, Dec. 08, 2025 (Korea Bizwire) – The Geneva College of Longevity Science (GCLS), in partnership with DrVibe.ai, today announced the launch of the GCLS AI Academy for Longevity Sciences—the world’s first [...]

EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025

Recognition follows a vote by professional and active traders, highlighting the critical role of execution quality in institutional-grade trading LONDON, Dec. 08, 2025 (Korea Bizwire) – EBC Financial Group (“EBC”) has been named Best Broker for Execution at the Professional Trader Awards 2025, organised by Holiston Media. Now in its sixth year, the programme recognises excellence across [...]

Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows

LONDON, Dec. 08, 2025 (Korea Bizwire) – A sharp acceleration in global wealth migration in 2025 is colliding with rapidly diverging private healthcare costs worldwide, making the availability and costs of reliable private care a decisive factor in where high-net-worth families choose to live, invest, and secure residence or citizenship rights. New client data released [...]

SHELL PLC THIRD QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS

December 8, 2025 The Board of Shell plc today announced the pounds sterling and euro equivalent dividend payments in respect of the third quarter 2025 interim dividend, which was announced on October 30, 2025 at US$0.358 per ordinary share. Shareholders have been able to elect to receive their dividends in US dollars, euros or [...]

NOTICE TO DISREGARD — ICARO Media Group

NEW YORK, Dec. 08, 2025 (Korea Bizwire) – We are advised by ICARO that certain information is subject to confidentiality agreements. Journalists and other readers should disregard the news release, “ICARO Media Group Enters New Multiyear Digital Network Deal with Elevator Giant Otis in Spain, Portugal and Africa,” issued November 25, 2025 10:27 ET, over GlobeNewswire. [...]

Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect

SINGAPORE, Dec. 07, 2025 (Korea Bizwire) – Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation, and interconnection solutions and an Oracle Partner, today announced it will offer connectivity to an Oracle Cloud Infrastructure (OCI) FastConnect point-of-presence (PoP) within the Oracle Cloud Singapore West Region. In addition to the new connectivity, [...]

$Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting$

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time resulted in a vein-to-vein time [...]

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty

MANILA, Philippines, Dec. 08, 2025 (Korea Bizwire) – A damning analysis from the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), entitled “The FCTC Secretariat’s Deepening Legitimacy Problem”, exposes how the World Health Organization’s Framework Convention on Tobacco Control has been captured by American philanthropist-funded NGOs, fundamentally undermining the treaty’s credibility and harming global public health [...]